The France medical devices market size was valued at USD 23.98 billion in 2024. The market is projected to grow from USD 25.15 billion in 2025 to USD 36.94 billion by 2032, exhibiting a CAGR of 5.6% during the forecast period.

Medical devices include instruments and products, especially designed for medical applications. The devices include diagnostics as well as therapeutic instruments. Further, medical devices are used for comprehensive analysis of body anatomy, disease indications, surgical procedures, and visualizations. Aging population, lucrative reimbursement policies, and consolidated healthcare infrastructure are some of the factors responsible for the market’s growth.

Moreover, growing collaborations amongst research institutes, universities, and private manufacturers are also offering a favorable opportunity. These partnerships lead to rapid product development, designing, and commercialization through distribution networks. Leading companies operating the market include F. Hoffmann-La Roche Ltd., Abbott, and Danaher Corporation. Further, the country also has a strong network of MedTech clusters, such as in Île-de-France and Auvergne-Rhône-Alpes, where innovation is supported through shared resources and funding opportunities.

MARKET DYNAMICS
Market Drivers

Consolidated Healthcare System to Have Positive Impact on Market Growth

The consolidated healthcare system in France is one of the prominent drivers positively impacting the France medical devices market growth. This healthcare system continuously focuses on the adoption of advanced medical technologies, consequently leading to the introduction of new products and technologies.

  • In July 2025, France-based start-up Spktrl announced the introduction of its new AI-powered light ring, a wearable technology developed for reducing mobile screen time. The ring automatically projects lights for urgent notifications, curbing the mobile screen time.

The country has a well-developed network of public and private hospitals, specialist clinics, and primary care centers that are continually upgrading their equipment to meet modern standards of care. This constant renewal cycle generates demand for new diagnostic tools, imaging systems, surgical instruments, and patient monitoring devices.

The healthcare system in France is also supported by favorable reimbursement policies, which play an important role in encouraging the adoption of medical devices and new technologies. Many advanced technologies are already covered by national health insurance schemes. 

Market Restraints

Longer Replacement Cycles of Equipment Negatively Impact the Market

Even though facilities in France eventually upgrade, many continue using older devices for years if they are still functioning well. This leads to low demand for certain products. The replacement cycle for capital equipment such as imaging systems or surgical robots is much longer.

Hospitals often focus on maintaining existing devices instead of buying new ones, which slows down the introduction of the latest technology. Furthermore, the institutes are focusing on entering into value partnerships for taking services instead of buying new instruments.

  • In October 2024, Siemens Healthineers entered into a 12-year contract with the University Hospital Nantes and its regional group of 13 public hospitals. Under this agreement, the company will be responsible for servicing and maintenance of imaging equipment. Such contracts lead to a longer lifecycle of products, consequently delaying the buying of new medical equipment.

Market Opportunities

Rising Demand for Home-Based Healthcare Solutions Present Favorable Growth

Rising demand for home-based healthcare solutions is expected to offer a lucrative opportunity for the France medical devices market. As the country is witnessing a substantial prevalence of chronic conditions along with a geriatric population, there is an increasing need for portable diagnostic tools, remote monitoring systems, and easy-to-use therapeutic devices. This shift of patient preference is supported by advancements in telemedicine, which allow doctors to track a patient’s health without frequent hospital visits.

  • In October 2023, Techcare, a telemonitoring solution, received the PECAN pathway in France. Through this, the product became the first reimbursed digital health device under regulatory authorities.

Moreover, these systems also help to reduce pressure on hospitals, which makes healthcare delivery more efficient. In addition, such a preference shift is expected to boost the innovation and development of advanced medical devices, offering a favorable environment for the France medical devices market.

Market Challenges

Shortage of Skilled Labor Prevents Regional Market’s Development

One of the major challenges for the medical devices market in France is the shortage of skilled healthcare professionals who are trained to operate and maintain advanced medical technologies. As healthcare providers are accepting more novel technologies such as robotic surgical systems and high-resolution imaging equipment, it creates a need for specialized personnel. However, training programs and recruitment have not always kept pace with the rapid introduction of these technologies.

  • According to a study published by a group of researchers in 2019, healthcare systems in France had 153 surgical robots. Also, according to data published on NCBI, an estimated 18% of the surgeons in France had actual experience of conducting thoracic robotic surgery in 2023.

This gap in resources leads to underutilization of expensive devices, longer periods of training, and delays in achieving full operational efficiency.

FRANCE MEDICAL DEVICES MARKET TRENDS

Increasing Integration of AI in Medical Devices

France medical device market space is witnessing a major trend of integration of artificial intelligence (AI) into diagnostic and imaging systems. Hospitals and diagnostic centers are strongly focusing on adopting AI-powered tools that can assist radiologists in faster detection of abnormalities with greater accuracy.

  • For instance, Philips and the radiology department of Hospices Civils de Lyon (HCL), France, are co-working to develop an AI-based algorithm to analyze thousands of CT scans on a daily basis. Some of the algorithms are also provided to radiologists through common sharing platforms.

The French government is also supporting this trend through its initiatives, such as the “France 2030” plan, which allocates funding to AI-based healthcare technologies.

Request a Free sample to learn more about this report.

SEGMENTATION ANALYSIS
By Type

Strong Focus of Government on Implementation of Health Programs Boost IVD’s Demand

Based on type, the market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging, IVD, MIS, wound management, diabetes care, ophthalmic, dental, nephrology, general surgery, and others.

The IVD segment dominated the France medical devices market share in 2024 as there is a substantial prevalence of chronic conditions, coupled with the active involvement of the government in implementing health programs. French healthcare policy actively encourages early detection, and lab-based testing is the first step in this process. Programs for prenatal screening, newborn testing, and regular monitoring of chronic diseases such as diabetes or cardiovascular conditions rely heavily on IVD devices.

  • For instance, in December 2022, the Ministry of Health and Prevention announced the extension of newborn screening for seven more conditions.

On the other hand, the orthopedic devices segment is projected to register a substantial CAGR during the forecast period. Certain factors, such as orthopedic conditions and the introduction of novel implants, are estimated to accelerate the segment’s growth.

To know how our report can help streamline your business, Speak to Analyst

By End-User

Adoption of Advanced Medical Devices Spur Hospitals & ASCs Growth

By end-user, the market is segregated into hospitals & ASCs, clinics, and others.

The hospitals and ASCs segment dominated the market in 2024. The large patient pool, coupled with the growing number of healthcare settings, is positively impacting the segment’s growth. In addition, favorable reimbursement policies are also projected to drive the adoption of medical devices in hospitals and ASCs.

The clinics segment is anticipated to exhibit the fastest CAGR over the forecast period supported by better accessibility of clinics, investments for the adoption of novel technologies, and a focus on overall cost reduction. In addition, favorable supportive policies and expansion of medical services in clinics also supports the clinic segment’s growth.

COMPETITIVE LANDSCAPE
Key Market Players

Innovation from Established Companies and Entry of New Players Creates Growth Environment in the Region

The medical devices market in France is fragmented with a considerable number of players operating.

Medtronic, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Abbott, and Danaher Corporation are some of the major players with a wide range of product portfolios. In addition, growing investment by these companies for new product launches, coupled with a strong focus on R&D to strengthen their product portfolio, support the medical devices market share of these companies in France.

There is a favorable environment for smaller enterprises as well as startups to enter the market, allowing new entrants trying to establish themselves with technologically advanced devices and products.

LIST OF KEY MEDICAL DEVICES COMPANIES IN FRANCE

KEY INDUSTRY DEVELOPMENTS

  • October 2024: GE HealthCare announced the commencement of its first production line in France. The company also introduced a French-made CT scanner at Centre Hospitalier de l’Agglomération Montargoise.

  • July 2024: Air Liquide Medical Systems announced the launch of Monnal TEO, a mechanical ventilator for intensive care units and critical centers.

  • June 2024: Insulet Corporation announced the launch of its new Omnipod 5 in France, which is an automated insulin delivery system.

  • October 2023: OMRON Healthcare Co., Ltd. announced the launch of its new AliveCor KardiaMobile portable ECG in France.

  • May 2021: Viant announced the completion of its facility expansion in France with an investment of USD 8.0 million.

REPORT COVERAGE

The report provides a detailed analysis of the market and focuses on key aspects such as prominent companies, product types, and end users of the product. Besides this, it offers insights into the medical devices market trends in France and highlights key industry developments and market share analysis for key companies. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

[BeHpklYYak]

Report Scope & Segmentation

ATTRIBUTE

DETAILS


Study Period

2019-2032


Base Year

2024


Estimated Year

2025


Forecast Period

2025-2032


Growth Rate

CAGR of 5.6% from 2025-2032


Historical Period

2019-2023


Unit

Value (USD Billion)


Segmentation

By Type

·         Orthopedic Devices

·         Cardiovascular Devices

·         Diagnostic Imaging

·         IVD

·         MIS

·         Wound Management

·         Diabetes Care

·         Ophthalmic

·         Dental

·         Nephrology

·         General Surgery

·         Others


By End-User

·         Hospitals & ASCs

·         Clinics

·         Others